<DOC>
	<DOCNO>NCT03026231</DOCNO>
	<brief_summary>The purpose study characterize intestinal flora subject Parkinson 's Disease ( PD ) determine safety trend improvement diversity colonic microbiome follow fecal microbiota transplantation .</brief_summary>
	<brief_title>Characterization Fecal Microbiome Changes After Administration PRIM-DJ2727 Parkinson 's Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnosis PD Hoehn Yahr stage &lt; 3 `` Off medicine '' state Sexually active male female subject childbearing potential must agree use effective method birth control treatment followup period Female subject childbearing potential must negative pregnancy test 72 hour procedure Subject willing sign inform consent form Subject deem likely survive â‰¥ 1 year enrolment Subject 's attend physician refer provide nontransplant care subject Subjects must demonstrate adherence ability maintain Parkinson 's therapy medical regimen stable 90 day enrolment participation study . Greater 20 gram ethanol intake daily Unstable Parkinson 's disease Other immune disorder clinical immunosuppression Probiotic use study period Severe underlie disease subject expect survive one year unstable medical condition require frequent change treatment Current recent within one month receipt antibiotic expect activity enteric bacteria Prior Deep Brain Stimulation , surgical intervention PD , intravenous glutathione therapy stem cell therapy HIV Hepatitis B / C positive</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Fecal microbiota transplantation</keyword>
</DOC>